Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Nicole M. Engel‐Nitz"'
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background To assess patient and primary care provider (PCP) factors associated with adherence to American Cancer Society (ACS) and United States Preventive Services Task Force (USPSTF) guidelines for average risk colorectal cancer (CRC) scr
Externí odkaz:
https://doaj.org/article/a41159ed472a4a488bde0185a3feccb4
Autor:
Mindie H. Nguyen, Lewis R. Roberts, Nicole M. Engel‐Nitz, Tim Bancroft, A. Burak Ozbay, Amit G. Singal
Publikováno v:
Hepatology Communications, Vol 6, Iss 12, Pp 3443-3456 (2022)
Abstract Suboptimal adherence to guidelines for hepatocellular carcinoma (HCC) surveillance among high‐risk patients is a persistent problem with substantial detriment to patient outcomes. While patients cite cost as a barrier to surveillance recei
Externí odkaz:
https://doaj.org/article/ac113ec59c9c416f8a1b0ccb19db7241
Publikováno v:
Preventive Medicine Reports, Vol 31, Iss , Pp 102082- (2023)
Colorectal cancer screening rates are important metrics for public health and quality indicators for health care systems; however, published estimates of colorectal cancer screening rates often include both high-risk and average-risk patients, and th
Externí odkaz:
https://doaj.org/article/a19538e577db427cb4db9c5c829b1989
Publikováno v:
COPD: Journal of Chronic Obstructive Pulmonary Disease. 17:499-508
Almost half of chronic obstructive pulmonary disease (COPD) exacerbations are estimated to be inaccurately reported by patients, inconsistently recorded in medical records, or not measured due to coding errors inherent to administrative claims. This
Autor:
Perry Meadows, Rachel C Lawton, Nicole M Engel-Nitz, John I. Allen, Eva Szigethy, Orna G Ehrlich, Sean M. Murphy, Caren Heller, Kim Henrichsen
Publikováno v:
Inflammatory Bowel Diseases. 27:40-48
Background Mental health diagnoses (MHDs) were identified as significant drivers of inflammatory bowel disease (IBD)-related costs in an analysis titled “Cost of Care Initiative” supported by the Crohn’s & Colitis Foundation. In this subanalysi
Publikováno v:
Vascular Health and Risk Management, Vol 2010, Iss default, Pp 905-913 (2010)
Nicole M Engel-Nitz1, Stephen D Sander2, Carolyn Harley3, Gabriel Gomez Rey1, Hemal Shah21Health Economic and Outcomes Research, i3 Innovus, Eden Prairie, MN, USA; 2Health Economic and Outcomes Research, Boehringer Ingelheim Pharmaceuticals, Inc., Ri
Externí odkaz:
https://doaj.org/article/a9eec3808b8f461d906542724fa4ff01
Autor:
Nicole M. Engel-Nitz, Carolyn Martin, Sanjeev Balu, Ilona J. Frieden, Amy Anderson, Angela Belland, Mary Lisha Paul
Publikováno v:
Journal of Vascular Anomalies. 3:e060
Autor:
Sean M. Murphy, Nicole M Engel-Nitz, Eva Szigethy, Kim Henrichsen, David T. Rubin, Rachel C Lawton, Perry Meadows, K.T. Park, Caren Heller, Sandra C. Kim, Orna G Ehrlich, Miguel Regueiro, John I. Allen
Publikováno v:
Inflammatory Bowel Diseases
This study quantifies the wide-ranging health care costs affecting patients living with IBD, including the annualized direct and indirect costs of care for patients with IBD, the longitudinal drivers of these costs, and the cost of care for newly dia
Autor:
Perry Meadows, Caren Heller, Eva Szigethy, Nicole M Engel-Nitz, Orna G Ehrlich, Sean M. Murphy, John I. Allen
Publikováno v:
Crohn's & Colitis 360. 3
Background Opioid use by patients with inflammatory bowel disease (IBD) has been associated with poorer health outcomes. This study describes socioeconomic characteristics; health utilization trends; and costs of patients with IBD and either no opioi
Autor:
Katrine L, Wallace, Adrienne, Landsteiner, Scott H, Bunner, Nicole M, Engel-Nitz, Amy N, Luckenbaugh
Publikováno v:
Cancer causescontrol : CCC. 32(12)
Numerous treatment breakthroughs for patients with metastatic castration-resistant prostate cancer (mCRPC) have been demonstrated in clinical trials in the past 15 years. However, real-world evidence on the changing epidemiology and longevity of this